BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31615671)

  • 1. Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity.
    El-Sayed ASA; Shindia AA; Zeid AAA; Yassin AM; Sitohy MZ; Sitohy B
    Enzyme Microb Technol; 2019 Dec; 131():109432. PubMed ID: 31615671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification, immobilization, and biochemical characterization of l-arginine deiminase from thermophilic Aspergillus fumigatus KJ434941: anticancer activity in vitro.
    El-Sayed AS; Hassan MN; Nada HM
    Biotechnol Prog; 2015; 31(2):396-405. PubMed ID: 25582958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillus Niger thermostable Cytosine deaminase-dextran conjugates with enhanced structure stability, proteolytic resistance, and Antiproliferative activity.
    El-Sayed ASA; Rady AM; Mohamed HT; Zein N; Yassin MA; Mohamed NZ; Hassan A; Amer MM; El-Sharakawy R; El-Sharkawy AA; El-Sayed N; Ali MG
    BMC Microbiol; 2023 Jan; 23(1):9. PubMed ID: 36627557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of peptidylarginine deiminase-like orthologs from thermotolerant Emericella dentata and Aspergillus nidulans.
    El-Sayed ASA; Shindia AA; AbouZaid AA; Yassin AM; Ali GS; Sitohy MZ
    Enzyme Microb Technol; 2019 May; 124():41-53. PubMed ID: 30797478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid evolution of arginine deiminase for improved anti-tumor activity.
    Ni Y; Liu Y; Schwaneberg U; Zhu L; Li N; Li L; Sun Z
    Appl Microbiol Biotechnol; 2011 Apr; 90(1):193-201. PubMed ID: 21221572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein engineering of the antitumor enzyme PpADI for improved thermal resistance.
    Zhu L; Cheng F; Piatkowski V; Schwaneberg U
    Chembiochem; 2014 Jan; 15(2):276-83. PubMed ID: 24375953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.
    Wang M; Basu A; Palm T; Hua J; Youngster S; Hwang L; Liu HC; Li X; Peng P; Zhang Y; Zhao H; Zhang Z; Longley C; Mehlig M; Borowski V; Sai P; Viswanathan M; Jang E; Petti G; Liu S; Yang K; Filpula D
    Bioconjug Chem; 2006; 17(6):1447-59. PubMed ID: 17105223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
    Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
    Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The electrostatic driving force for nucleophilic catalysis in L-arginine deiminase: a combined experimental and theoretical study.
    Li L; Li Z; Wang C; Xu D; Mariano PS; Guo H; Dunaway-Mariano D
    Biochemistry; 2008 Apr; 47(16):4721-32. PubMed ID: 18366187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a recombinant arginine deiminase from Halothermothrix orenii and its application in citrulline production.
    Wang W; Li M; Miao M; Zhang T
    Biotechnol Appl Biochem; 2023 Apr; 70(2):526-536. PubMed ID: 35761421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directed evolution of an antitumor drug (arginine deiminase PpADI) for increased activity at physiological pH.
    Zhu L; Tee KL; Roccatano D; Sonmez B; Ni Y; Sun ZH; Schwaneberg U
    Chembiochem; 2010 Mar; 11(5):691-7. PubMed ID: 20157910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine Deiminase Enzyme Evolving as a Potential Antitumor Agent.
    Somani RR; Chaskar PK
    Mini Rev Med Chem; 2018; 18(4):363-368. PubMed ID: 27538511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of a dimeric arginine deiminase from Enterococcus faecium GR7 and study of its anti-cancerous activity.
    Kaur B; Kaur R
    Protein Expr Purif; 2016 Sep; 125():53-60. PubMed ID: 26363115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein.
    Lee H; Park G; Kim S; Son B; Joo J; Park HH; Park TH
    Appl Microbiol Biotechnol; 2022 Nov; 106(22):7531-7545. PubMed ID: 36227339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermostability and Specific-Activity Enhancement of an Arginine Deiminase from Enterococcus faecalis SK23.001 via Semirational Design for l-Citrulline Production.
    Cai X; Jiang H; Zhang T; Jiang B; Mu W; Miao M
    J Agric Food Chem; 2018 Aug; 66(33):8841-8850. PubMed ID: 30047723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylation and pharmacological characterization of a potential anti-tumor drug, an engineered arginine deiminase originated from Pseudomonas plecoglossicida.
    Zhang L; Liu M; Jamil S; Han R; Xu G; Ni Y
    Cancer Lett; 2015 Feb; 357(1):346-354. PubMed ID: 25462857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug.
    Han RZ; Xu GC; Dong JJ; Ni Y
    Appl Microbiol Biotechnol; 2016 Jun; 100(11):4747-60. PubMed ID: 27087524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of arginine deiminase from Pseudomonas putida: Structural insights of the differential affinities of l-arginine analogues.
    Patil MD; Rathod VP; Bihade UR; Banerjee UC
    J Biosci Bioeng; 2019 Feb; 127(2):129-137. PubMed ID: 30143336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism.
    Das K; Butler GH; Kwiatkowski V; Clark AD; Yadav P; Arnold E
    Structure; 2004 Apr; 12(4):657-67. PubMed ID: 15062088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells.
    Yeh TH; Chen YR; Chen SY; Shen WC; Ann DK; Zaro JL; Shen LJ
    Mol Pharm; 2016 Jan; 13(1):262-71. PubMed ID: 26642391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.